![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 47/56 | |
A61K 31/70 | |||
A61K 31/713 |
(11) | Number of the document | 2231195 |
(13) | Kind of document | T |
(96) | European patent application number | 08865121.1 |
Date of filing the European patent application | 2008-12-04 | |
(97) | Date of publication of the European application | 2010-09-29 |
(45) | Date of publication and mention of the grant of the patent | 2017-03-29 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2008/085582 |
Date | 2008-12-04 |
(87) | Number | WO 2009/082607 |
Date | 2009-07-02 |
(30) | Number | Date | Country code |
992309 P | 2007-12-04 | US | |
127751 P | 2008-05-14 | US | |
91093 P | 2008-08-22 | US | |
97261 P | 2008-09-16 | US | |
13597 P | 2007-12-13 | US |
(72) |
MANOHARAN, Muthiah, US
RAJEEV, Kallanthottathil, G., US
NARAYANANNAIR, Jayaprakash, K., US
JAYARAMAN, Muthusamy, US
|
(73) |
Arbutus Biopharma Corporation,
100- 8900 Glenlyon Parkway, Burnaby, BC V5J 5J8,
CA
|
(54) | TARGETING LIPIDS |
TARGETING LIPIDS |